Back to search results

TMS for Opioid and Alcohol Use Disorder Recovery

This study is looking at whether Transcranial Magnetic Stimulation (TMS) can help people recovering from Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD). TMS uses magnetic pulses to stimulate brain cells. Participants will receive either a 3-minute or 9-minute TMS treatment each morning for four weeks, alongside their regular therapy. The researchers want to see if TMS helps with things like cravings, withdrawal symptoms, and overall well-being. You can join if you are 18 or older, enrolled in the Intensive Outpatient Program at Another Chance Drug & Alcohol Rehab Center in Portland, OR, and have both OUD and AUD. The study is currently recruiting 60 participants, but its exact status is unclear.

Study design
This is a randomized, controlled study with three groups. It aims to enroll 60 participants to compare different TMS treatments.
What's involved
Participants will receive TMS treatments for 5 days a week over four weeks, in addition to their regular therapy activities. They will also complete surveys.
Compensation
Not stated in the trial record.
Follow-up
The main outcomes of the study are measured at 4 weeks after starting treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07171359

TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

Recruiting
NAAges 18+InterventionalTreatment
Washington State University
~60 participants
Updated 2026-05-29 on ClinicalTrials.gov
What's tested:TMS Low-DoseTMS High-Dose

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Engagement in Treatment As Usual activities
Measured over 4 weeks
+3 more outcomes measured

Conditions

Alcohol Use Disorder
Opioid Use Disorder

Explore related trials

Alcohol use disorderOpioid Use Disorder

Where it's being run

1 sites across 1 states
Oregon1

Study leadership

  • Matthew E Layton, MD, PhD · PRINCIPAL_INVESTIGATOR · Washington State University

Who to contact

Matthew E Layton, MD, PhD
[email protected]
509-389-1108
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18+ years old
Enrolled in the Intensive Outpatient Program at Another Chance Drug \& Alcohol Rehab Center of Portland, Portland, OR.
Diagnosed with Opioid Use Disorder
Diagnosed with Alcohol Use Disorder

Exclusion

Children \<18 years old
Pregnant
Non-English speaking
Currently taking prescription benzodiazepines or anti-convulsive medications
In active alcohol or opioid withdrawal
History of seizure disorder diagnosis
History of Schizophrenia, Bipolar Disorder, Mania

What this trial measures

  • Engagement in Treatment As Usual activities4 weeks

    The Investigators will compare engagement in treatment as usual within and between groups by Number of Days in attendance from baseline assessment to follow up.

  • Engagement in Treatment As Usual Activities4 weeks

    Number of individual treatment sessions attended from baseline assessment to follow up.

  • Engagement in Treatment As Usual Activities4 weeks

    Number of group treatment sessions attended from baseline assessment to follow up.

  • Engagement in Treatment As Usual Activities4 weeks

    Number of negative urine toxicology screens for illicit drugs or unprescribed medications from baseline assessment to follow up.